Bolt Biotherapeutics
5 followers
Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical stu... Read more
Org chart
Willie Quinn
President & CEO
Willie Quinn
Collapse
Calvin Leung
Senior Director, Corporate Controller
Dawn Colburn
SVP, Clinical Development
Grant Yonehiro
Coo/cbo
Lu Xu
VP, Developmental Science
Lynn Ferguson Lewis
Head Of Information Technology
Michael N. Alonso
VP, Immunology & Pharmacology
Nathan Ihle
Senior Vp, Pharmaceutical Operations
Pam Howland
VP, Portfolio & Program Management
Sarah Nemec
VP, Finance & Principal Accounting Officer
Wesley Burwell
VP, Head of HR
